Leadership & Pay ·
PDS Biotechnology Corporation announced a reduction in force affecting approximately 36% of its workforce to align…
PDSBPDS Biotechnology Corp
PDS Biotechnology Corporation announced a reduction in force affecting approximately 36% of its workforce to align expenses with strategic priorities focused on PDS0301. The company expects to record a one-time charge of approximately $842,000 for employee separation benefits in the third quarter of 2026. Concurrently, the company terminated Stephan Toutain as Chief Operating Officer without cause. Mr. Toutain is entitled to severance comprising twelve months of base salary and COBRA health care contributions. PDS Biotechnology Corporation operates in the biopharmaceutical industry, developing treatments for rare diseases.